Sialic acid binding Ig like lectins

Home
Targets
Other protein targets
Sialic acid binding Ig like lectins

Unless otherwise stated all data on this page refer to the human proteins. Gene information is provided for human (Hs), mouse (Mm) and rat (Rn).

Overview

Show »« Hide

SIGLECs are a family of type I transmembrane proteins that are predominantly expressed by hemopoietic cells and they play critical roles in immune cell signalling and discrimination of self and nonself. The SIGLECs act as checkpoints in immune responses in human diseases including cancer, asthma, allergy, neurodegeneration, and autoimmune diseases and are being investigated as therapeutic targets [3-4].

Targets

Targets of relevance to immunopharmacology are highlighted in blue

SIGLEC2 (CD22) Show summary »« Hide summary More detailed page go icon to follow link

Target Id	2786
Nomenclature	CD22
Common abbreviation	SIGLEC2
Previous and unofficial names	B-lymphocyte cell adhesion molecule \| sialic acid binding Ig-like lectin 2 \| SIGLEC-2
Genes	CD22 (Hs)
Ensembl ID	ENSG00000012124 (Hs)
UniProtKB AC	P20273 (Hs)

SIGLEC3 (CD33) C Show summary »« Hide summary More detailed page go icon to follow link

SIGLEC8 (sialic acid binding Ig like lectin 8) Show summary »« Hide summary More detailed page go icon to follow link

SIGLEC10 (sialic acid binding Ig like lectin 10) Show summary »« Hide summary More detailed page go icon to follow link

References

Show »« Hide

1. Bernstein ID. (2000) Monoclonal antibodies to the myeloid stem cells: therapeutic implications of CMA-676, a humanized anti-CD33 antibody calicheamicin conjugate. Leukemia, 14 (3): 474-5. [PMID:10720144]

2. Caron PC, Co MS, Bull MK, Avdalovic NM, Queen C, Scheinberg DA. (1992) Biological and immunological features of humanized M195 (anti-CD33) monoclonal antibodies. Cancer Res, 52 (24): 6761-7. [PMID:1458463]

3. Duan S, Paulson JC. (2020) Siglecs as Immune Cell Checkpoints in Disease. Annu Rev Immunol, 38: 365-395. [PMID:31986070]

4. Gibbons A. (2020) How an ancient microbial arms race remodeled human cells. Science, 369 (6503): 491-492. [PMID:32732402]

5. Zheng X, Wu W, Liu Y, Zheng P. (2013) Methods of use of soluble cd24 for therapy of rheumatoid arthritis. Patent number: US20130231464A1. Assignee: Oncolmmune, Inc.. Priority date: 28/04/2010. Publication date: 05/09/2013.

How to cite this family page

Database page citation:

Sialic acid binding Ig like lectins. Accessed on 09/12/2023. IUPHAR/BPS Guide to PHARMACOLOGY, http://www.guidetopharmacology.org/GRAC/FamilyDisplayForward?familyId=1000.

Concise Guide to PHARMACOLOGY citation:

Alexander SP, Kelly E, Mathie A, Peters JA, Veale EL et al. (2021) THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: Introduction and Other Protein Targets. Br J Pharmacol. 178 Suppl 1:S1-S26.